Contents
	Home
	Questions and Answers About TB
	TB Guidelines
	Fact Sheets
	Education/Training Materials
	Slide Sets
	TB-Related MMWRs & Articles
	Surveillance Reports
	World TB Day
	TB in African Americans
	TB-Related Links

Resources
	State TB Control Offices
	Order Publications
	TB Education & Training Network (TB ETN)
	TB Information Management
	TB Epidemiologic Studies Consortium
	International Notification of TB Cases
	Regional Training and Medical Consultation Centers (RTMCCs)
	Laboratory Services
	TB Trials Consortium

U.S. Department of Health and Human Services

TB Guidelines

On this page —

TB Guidelines
Archived TB Guidelines

Title	Format	Date Published
Notice to Readers: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis	PDF	1/2008
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis	PDF	1/2008
Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC MMWR 2006; 55 (No. RR–09, 1–44)	PDF	7/2006
Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 MMWR 2005; 54 (No. RR-17, 1-141) Errata (September 25, 2006) (PDF - 131k) Additional FAQ's for Clarification of Recommendations in the Guidelines (PDF - 111k) Appendix B. Tuberculosis (TB) Risk Assessment Worksheet (PDF - 195k) (MS Word format)	PDF	12/2005
Health Information for International Travel		1/2005–2006
Guidelines for Using the QuantiFERON–TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States MMWR 2005; 54 (No. RR–15, 1–37)	PDF	12/2005
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC MMWR 2005; 54 (No. RR–15, 1–37)	PDF	12/2005
Controlling Tuberculosis in the United States Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America MMWR 2005; 54 (No. RR–12)	PDF	11/2005
National Plan for Reliable Tuberculosis Laboratory Services Using a Systems Approach MMWR 2005; 54 (RR–6)	PDF	4/2005
Errata: Treatment of Tuberculosis MMWR 2005; 52 (RR–11)	PDF	1/2005
Treating Opportunistic Infections Among HIV–Infected Adults and Adolescents MMWR 2004; 53 (RR15)	PDF	12/2004
Treating Opportunistic Infections Among HIV–Exposed and Infected Children MMWR 2004; 53 (RR14)	PDF	12/2004
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor – Alpha – California, 2002–2003 MMWR 2004; 53 (No. 30)	PDF	8/2004
Guide to the Application of Genotyping to Tuberculosis Prevention and Control	PDF	6/2004
Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection MMWR 2003; 52 (No. 31)	PDF	8/2003
Treatment of Tuberculosis MMWR 2003; 52 (No. RR–11) Errata TB Treatment Guidelines in PDA Format	PDF	6/2003
Guidelines for Environmental Infection Control in Health–Care Facilities MMWR 2003; 52 (No. RR–10)	PDF	6/2003
Timing of Tuberculosis Screening and Smallpox Vaccination – Recommendations for Using Smallpox Vaccine in a Pre–Event Vaccination Program MMWR 2003; 52 (No. RR–7)	PDF	4/2003
Guidelines for Preventing Opportunistic Infections Among HIV–Infected Persons — 2002 MMWR 2002; 51 (No. RR–8)	PDF	6/2002
Progressing Toward Tuberculosis Elimination in Low–Incidence Areas of the United States MMWR 2002; 51 (No. RR–5)	PDF	5/2002
General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP) MMWR 2002; 51 (No. RR–2).	PDF	2/2002
Preventing and Controlling Tuberculosis Along the U.S.–Mexico Border Work Group Report MMWR 2001; 50 (No. RR–1)	PDF	1/2001
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR 2000; 49 (No. RR–6) Updates	PDF	6/2000
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors MMWR 2000; 49 (No. 9)	PDF	3/2000
Diagnostic Standards / Classification of TB in Adults and Children — Am J Respir Crit Care Med 2000; 161	PDF	2000
Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment (ACET) MMWR 1999; 48 (No. RR–9)	PDF	8/1999
Recommendations for Prevention and Control of Tuberculosis among Foreign–Born Persons MMWR 1998; 47 (No. RR–16)	PDF	9/1998
Development of new Vaccines for Tuberculosis MMWR 1998; 47 (No. RR–13)	PDF	8/1998
Prevention and Control of Tuberculosis in Correctional Facilities (ACET) MMWR 1996; 45 (No. RR–8)	PDF	6/1996
The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. (ACET and ACIP) MMWR 1996; 45 (RR–4)	PDF	4/1996
Essential Components of a Tuberculosis Prevention and Control Program (ACET) MMWR 1995; 44 (No. RR–11)	PDF	9/1995
Tuberculosis Control Laws – United States, 1993 (ACET) MMWR 1993; 42 (No. RR–15)	PDF	11/1993

Archived TB Guidelines

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

Title	Format	Date Published
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors MMWR 2004; 53 (No. 2)	PDF	1/2004
Guidelines for Using the QuantiFERON®–TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection MMWR 2002; 51 (12/18/02)	PDF	1/2003
Public Health Dispatch: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection MMWR 2002; 51 (No. 44)	PDF	11/2002
Diagnostic Standards / Classification of TB in Adults and Children Am J Respir Crit Care Med 2000; 161	PDF	7/1999
Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations MMWR 1998; 47 (No. RR–20)	PDF	10/1998
Anergy Skin Testing and Preventive Therapy for HIV–Infected Persons: Revised Recommendations MMWR 1997; 46 (No. RR–15)	PDF	9/1997
Screening for Tuberculosis and Tuberculosis Infection in High–Risk Populations (ACET) MMWR 1995; 44 (No. RR–11)	PDF	9/1995
Guidelines for Preventing the transmission of Mycobacterium tuberculosis in Health–Care Facilities, 1994 MMWR 1994; 43 (No. RR–13)	PDF	10/1994
Treatment of Tuberculosis and Tuberculosis Infection Am J Respir Crit Care Med 1994; 149	PDF	1994
Prevention and Control of Tuberculosis in Migrant Farm Workers (ACET) MMWR 1992; 41 (No. RR–10)	N/A	6/1992
National Action Plan to Combat Multidrug–Resistant Tuberculosis MMWR 1992; 41 (RR–11)	N/A	6/1992
Management of Persons Exposed to Multidrug–Resistant Tuberculosis MMWR 1992; 41 (RR–11)	N/A	6/1992
Prevention and Control of Tuberculosis in U.S. Communities with At–Risk Minority Populations (ACET) MMWR 1992; 41 (No. RR–5)	N/A	4/1992
Prevention and Control of Tuberculosis Among Homeless Persons (ACET) MMWR 1992; 41 (No. RR–5)	N/A	4/1992
Control of Tuberculosis in the U.S. Am Rev Respir Dis 1992; 146	PDF	3/1992
Prevention and Control of Tuberculosis in Facilities Providing Long–Term Care to the Elderly (ACET) MMWR 1990; 39 (RR–10)	N/A	7/1990
Diagnostic Standards / Classification of TB Am Rev Respir Dis 1990; Volume 142 (3)	PDF	1990
A Strategic Plan for the Elimination of Tuberculosis in the United States MMWR 1989; 38 (S–3).	N/A	4/1989

Return to TB Guidelines Main Menu

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov